AAAAAA
Results: 1-25/40
Authors:
AAPRO MS
MARTIN C
HATTY S
Citation: Ms. Aapro et al., GEMCITABINE - A SAFETY REVIEW, Anti-cancer drugs, 9(3), 1998, pp. 191-201
Authors:
HERRSTEDT J
AAPRO MS
SMYTH JF
DELFAVERO A
Citation: J. Herrstedt et al., CORTICOSTEROIDS, DOPAMINE ANTAGONISTS AND OTHER DRUGS, Supportive care in cancer, 6(3), 1998, pp. 204-214
Authors:
ROILA F
DELFAVERO A
GRALLA RJ
TONATO M
AAPRO MS
ANDREWS PLR
BALLATORI E
DEMULDER PHM
DICATO MA
DUBOIS A
FEYER PC
GANDARA DR
GRALLA RJ
GRALLA RJ
GROSHEN S
GRUNBERG SM
HERRSTEDT J
HESKETH PJ
JOSS RA
KRIS MG
MARTY MM
MORROW GR
NAYLOR RJ
OLVER IN
SMYTH JF
SPITZER TR
STEWART A
Citation: F. Roila et al., PREVENTION OF CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED EMESIS - RESULTS OF THE PERUGIA CONSENSUS CONFERENCE, Annals of oncology, 9(8), 1998, pp. 811-819
Authors:
DEPAS T
DEBRAUD F
ORLANDO L
NOLE F
MUNZONE E
ZAMPINO MG
FAZIO N
AAPRO MS
GOLDHIRSCH A
Citation: T. Depas et al., HIGH-DOSE IFOSFAMIDE PLUS ADRIAMYCIN IN THE TREATMENT OF ADULT ADVANCED SOFT-TISSUE SARCOMAS - IS IT FEASIBLE, Annals of oncology, 9(8), 1998, pp. 917-919
Authors:
STUPP R
ROWELL NP
ORECCHIA R
OZSAHIN M
POPOWSKI Y
AAPRO MS
MICHEL G
KRENGLI M
WEINER J
GOEDKOOP R
MIRIMANOFF RO
Citation: R. Stupp et al., RECOMBINANT INTERFERON-BETA (REBIF(R)) AS A RADIOSENSITIZER IN NON-SMALL-CELL LUNG-CANCER (NSCLC) - EARLY RESULTS OF A PHASE I II TRIAL/, Annals of oncology, 9, 1998, pp. 328-328
Authors:
DEBRAUD F
MUNZONE E
NOLE F
DEPAS T
BIFFI R
BRIENZA S
AAPRO MS
Citation: F. Debraud et al., SYNERGISTIC ACTIVITY OF OXALIPLATIN AND 5-FLUOROURACIL IN PATIENTS WITH METASTATIC COLORECTAL-CANCER WITH PROGRESSIVE DISEASE WHILE ON OR AFTER 5-FLUOROURACIL, American journal of clinical oncology, 21(3), 1998, pp. 279-283
Authors:
AAPRO MS
Citation: Ms. Aapro, NEW CLINICAL STRATEGIES FOR SYMPTOM MANAGEMENT AND QUALITY-OF-LIFE ENHANCEMENT IN CANCER-PATIENTS - INTRODUCTION, European journal of cancer, 33, 1997, pp. 1-2
Authors:
CROOCKEWIT AJ
BRONCHUD MH
AAPRO MS
BARGETZI MJ
CROWN J
GRATWOHL A
LANGE W
LUDWIG H
MARTINELLI G
MERTELSMANN R
NUESSLER V
WILLEMZE R
DEWITTE TJM
ZITTOUN R
ZWIERZINA H
Citation: Aj. Croockewit et al., A EUROPEAN PERSPECTIVE ON HEMATOPOIETIC GROWTH-FACTORS IN HEMATOONCOLOGY - REPORT OF AN EXPERT MEETING OF THE EORTC, European journal of cancer, 33(11), 1997, pp. 1732-1746
Authors:
AAPRO MS
Citation: Ms. Aapro, ALWAYS MORE SETRONS - HOW MANY DO WE NEED, Supportive care in cancer, 5(1), 1997, pp. 1-2
Authors:
AAPRO MS
Citation: Ms. Aapro, 5HT(3) ANTAGONISTS AND RADIOTHERAPY - RESPONSE, Annals of oncology, 8(3), 1997, pp. 302-302
Authors:
HESKETH PJ
KRIS MG
GRUNBERG SM
BECK T
HAINSWORTH JD
HARKER G
AAPRO MS
GANDARA D
LINDLEY CM
Citation: Pj. Hesketh et al., PROPOSAL FOR CLASSIFYING THE ACUTE EMETOGENICITY OF CANCER-CHEMOTHERAPY, Journal of clinical oncology, 15(1), 1997, pp. 103-109
Authors:
AUDISIO RA
CAZZANIGA M
ROBERTSON C
VERONESI P
ANDREONI B
AAPRO MS
Citation: Ra. Audisio et al., ELECTIVE SURGERY FOR COLORECTAL-CANCER IN THE AGED - A CLINICAL-ECONOMICAL EVALUATION, British Journal of Cancer, 76(3), 1997, pp. 382-384
Authors:
AAPRO MS
Citation: Ms. Aapro, UNTITLED, Critical reviews in oncology/hematology, 24(1), 1996, pp. 1-1
Authors:
AAPRO MS
Citation: Ms. Aapro, UNTITLED, Critical reviews in oncology/hematology, 22(1), 1996, pp. 5-5
Authors:
PIAMSOMBOON S
TERMRUNGRUANGLERT W
KUDELKA AP
EDWARDS CL
FREEDMAN RS
MOUNTAIN CF
DELCLOS L
AAPRO MS
DECARO L
BIANCA J
VERSCHRAEGEN CF
KAVANAGH JJ
Citation: S. Piamsomboon et al., PROLONGED STABILIZATION OF PROGRESSIVE SQUAMOUS-CELL CANCER OF THE CERVIX WITH INTERFERON-ALPHA AND 13-CIS-RETINOIC ACID - REPORT OF 2 CASES AND REVIEW OF THE LITERATURE, Anti-cancer drugs, 7(7), 1996, pp. 800-804
Authors:
AAPRO MS
Citation: Ms. Aapro, RADIOTHERAPY AND DRUGS - SETRONS ONCE AGAIN, Annals of oncology, 7(6), 1996, pp. 553-554
Authors:
AAPRO MS
Citation: Ms. Aapro, ORAL ETOPOSIDE AND PALLIATIVE TREATMENT FOR SMALL-CELL LUNG-CANCER, Lancet, 348(9027), 1996, pp. 559-559
Authors:
AAPRO MS
Citation: Ms. Aapro, QUALITY-OF-LIFE, QUALITY OF CARE IN ONCOLOGY - ROUND-TABLE MEETING HELD IN CONJUNCTION WITH THE 19TH CONGRESS OF THE EUROPEAN-SOCIETY-OF-MEDICAL-ONCOLOGY (ESMO), LISBON, PORTUGAL, 21 NOVEMBER 1994 - FOREWORD, European journal of cancer, 31A, 1995, pp. 1-1
Authors:
AAPRO MS
Citation: Ms. Aapro, RETINOIDS IN ONCOLOGY, European journal of cancer, 31A(5), 1995, pp. 834-835
Authors:
DEPREE C
AAPRO MS
SPILIOPOULOS A
POPOWSKI Y
MERMILLOD B
MIRIMANOFF RO
ALBERTO P
Citation: C. Depree et al., COMBINED CHEMOTHERAPY AND RADIOTHERAPY, FOLLOWED OR NOT BY SURGERY, IN SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS, Annals of oncology, 6(6), 1995, pp. 551-557
Authors:
AAPRO MS
Citation: Ms. Aapro, DOCETAXEL (TAXOTERE) - A HIGHLY-ACTIVE TAXOID WITH MANAGEABLE TOXICITY, Seminars in oncology, 22(2), 1995, pp. 1-2
Authors:
AAPRO MS
Citation: Ms. Aapro, COSTS AND BENEFITS OF ANTIEMETIC THERAPY, Supportive care in cancer, 2(5), 1994, pp. 304-306
Authors:
AAPRO MS
Citation: Ms. Aapro, ONCE MORE - PREVENTION OF NAUSEA AND EMESIS IN CANCER-TREATMENT, Supportive care in cancer, 2(3), 1994, pp. 141-142
Authors:
JOSS RA
BACCHI M
BUSER K
KIRCHNER V
NEUENSCHWANDER H
ORTH B
AAPRO MS
THURLIMANN B
Citation: Ra. Joss et al., ONDANSETRON PLUS DEXAMETHASONE IS SUPERIOR TO ONDANSETRON ALONE IN THE PREVENTION OF EMESIS IN CHEMOTHERAPY-NAIVE AND PREVIOUSLY TREATED PATIENTS, Annals of oncology, 5(3), 1994, pp. 253-258
Authors:
AAPRO MS
Citation: Ms. Aapro, PERHAPS NOT EVERYONE KNOWS THAT, Annals of oncology, 5(2), 1994, pp. 106-107